Havn Life Sciences Inc (HAVN.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 04/30
(Values in thousands)
| 04-2022 | 04-2021 | 04-2020 | |
| Cash Flows From Operating Activities | |||
| Depreciation Amortization | 576 | 4,605 | N/A |
| Accounts receivable | -109 | -207 | N/A |
| Other Working Capital | -536 | -615 | -34 |
| Other Operating Activity | -7,805 | -14,205 | -41 |
| Operating Cash Flow | $-7,875 | $-10,422 | $-75 |
| Cash Flows From Investing Activities | |||
| PPE Investments | -75 | -33 | N/A |
| Net Acquisitions | -1,200 | -346 | N/A |
| Other Investing Activity | -756 | -18 | -250 |
| Investing Cash Flow | $-2,031 | $-397 | $-250 |
| Cash Flows From Financing Activities | |||
| Debt Repayment | -131 | -33 | N/A |
| Common Stock Issued | 2,000 | 14,133 | 1,922 |
| Other Financing Activity | -309 | 4,503 | 20 |
| Financing Cash Flow | $1,560 | $18,603 | $1,942 |
| Beginning Cash Position | 9,402 | 1,617 | 0 |
| End Cash Position | 1,056 | 9,402 | 1,617 |
| Net Cash Flow | $-8,346 | $7,785 | $1,617 |
| Free Cash Flow | |||
| Operating Cash Flow | -7,875 | -10,422 | -75 |
| Capital Expenditure | -103 | -33 | N/A |
| Free Cash Flow | -7,978 | -10,455 | -75 |